Organization Overview
Historical Acquisition Tree
Alternative names
Key: Genentech (29) Acquired (1)
alteplase (Activase) (1987)
atezolizumab (tecentriq) (2016 NDA)
baloxavir marboxil (xofluza) (2018)
bevacizumab (avastin) (2004 NDA)
cobimetinib (cotellic) (2015 NDA)
dornase alfa (pulmozyme) (1993 NDA)
efalizumab (raptiva) (2003 NDA)
emicizumab (Hemlibra) (2018 NDA)
entrectinib (Rozlytrek) (2019)
faricimab (Vabysmo) (2022)
growth hormone (protropin) (1985 NDA)
hyaluronidase (human recombinant) (hylenex) (2017)
mosunetuzumab (2022)
obinutuzumab (gazyva) (2013 NDA)
ocrelizumab (ocrevus) (2017)
omalizumab (xolair) (2003 NDA)
pertuzumab (perjeta) (2012 NDA)
pirfenidone (esbriet) (2014)
polatuzumab vedotin (Polivy) (2019)
pralsetinib (2020)
ranibizumab (lucentis) (2006 NDA)
risdiplam (2020)
rituximab (rituxan) (1997)
satralizumab (Enspryng) (2020)
somatropin (protropin) (1979)
tenecteplase (tnkase) (2000 NDA)
tocilizumab (actemra) (2010)
trastuzumab (herceptin) (1998)
trastuzumab emtansine (kadcyla) (2013 NDA)
vismodegib (erivedge) (2012 NDA)
Key: Genentech (41) Acquired (1)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (2 trials)
adalimumab (humira) (4 trials)
alteplase (Activase) (21 trials)
atezolizumab (tecentriq) (102 trials)
azacitidine (vidaza) (9 trials)
baloxavir marboxil (xofluza) (1 trial)
betamethasone (celestone) (1 trial)
bevacizumab (avastin) (324 trials)
dornase alfa (pulmozyme) (12 trials)
efalizumab (raptiva) (23 trials)
emicizumab (Hemlibra) (6 trials)
estradiol (progynon depot) (1 trial)
etanercept (enbrel) (2 trials)
fluticasone (cutivate) (1 trial)
growth hormone (protropin) (1 trial)
acetaminophen (tylenol) (5 trials)
acetylsalicylic acid (aspirin) (2 trials)
aflibercept (zaltrap) (5 trials)
anastrozole (arimidex) (5 trials)
azathioprine (imuran) (3 trials)
basiliximab (simulect) (1 trial)
bendamustine (treanda) (14 trials)
bleomycin (blenoxane) (3 trials)
bortezomib (velcade) (10 trials)
capecitabine (xeloda) (30 trials)
carboplatin (paraplatin) (80 trials)
chlorambucil (Leukeran) (4 trials)
cobimetinib (cotellic) (37 trials)
cyclophosphamide (cytoxan) (49 trials)
cyclosporine (sandimmune) (1 trial)
cytarabine (cytosar-u) (6 trials)
diphenhydramine (benadryl) (7 trials)
docetaxel (taxotere) (46 trials)
doxorubicin (Doxil) (33 trials)
epirubicin (ellence) (6 trials)
erlotinib (tarceva) (115 trials)
etoposide (vepesid) (19 trials)
filgrastim (neupogen) (4 trials)
fludarabine (fludara) (14 trials)
fluorouracil (efudex) (41 trials)
gemcitabine (gemzar) (51 trials)
interferon alpha-2b (Intron-A) (3 trials)
leflunomide (arava) (2 trials)
methylprednisolone (medrol) (13 trials)
mitomycin (mutamycin) (2 trials)
mitoxantrone (novantrone) (5 trials)
mycophenolate (myfortic) (10 trials)
obinutuzumab (gazyva) (43 trials)
pertuzumab (perjeta) (39 trials)
pirfenidone (esbriet) (13 trials)
procarbazine (matulane) (1 trial)
salmeterol (serevent) (1 trial)
trastuzumab (herceptin) (66 trials)
trastuzumab emtansine (kadcyla) (22 trials)
valganciclovir (valcyte) (2 trials)
vemurafenib (zelboraf) (25 trials)
Key: Genentech (189) Acquired (2)
abemaciclib (verzenio) (3 trials)
abiraterone (zytiga) (2 trials)
acalabrutinib (calquence) (3 trials)
aldesleukin (proleukin) (1 trial)
alectinib (alecensa) (7 trials)
allogeneic gm-csf-secreting breast cancer vaccine (1 trial)
allogeneic stem cells (1 trial)
allopurinol (zyloprim) (1 trial)
aminolevulinic acid (levulan) (1 trial)
atorvastatin (lipitor) (1 trial)
autologous hematopoietic cell (1 trial)
azithromycin (zithromax) (1 trial)
bexarotene (targretin) (3 trials)
bicalutamide (casodex) (3 trials)
cabozantinib (cometriq) (3 trials)
carfilzomib (kyprolis) (1 trial)
cetuximab (erbitux) (9 trials)
cladribine (leustatin) (1 trial)
clopidogrel (plavix) (1 trial)
crizotinib (xalkori) (1 trial)
cyanocobalamin (berocca) (2 trials)
dacarbazine (dtic-dome) (2 trials)
daratumumab (darzalex) (6 trials)
dasatinib (sprycel) (3 trials)
decitabine (dacogen) (3 trials)
entrectinib (Rozlytrek) (7 trials)
enzalutamide (xtandi) (3 trials)
erdafitinib (Balversa) (1 trial)
erythromycin (ilosone) (1 trial)
escitalopram (lexapro) (1 trial)
everolimus (zortress) (16 trials)
fexofenadine (allegra) (1 trial)
fludeoxyglucose f-18 (1 trial)
fulvestrant (faslodex) (8 trials)
ganciclovir (cytovene) (1 trial)
goserelin (zoladex) (2 trials)
hemopoietic stem cell (1 trial)
hyaluronidase (human recombinant) (hylenex) (3 trials)
hydroxychloroquine (plaquenil) (3 trials)
ibalizumab-uiyk (trogarzo) (1 trial)
ibritumomab tiuxetan (zevalin) (1 trial)
ibrutinib (imbruvica) (7 trials)
immune globulin (human) (1 trial)
interferon beta-1b (betaseron) (1 trial)
ipilimumab (yervoy) (2 trials)
irinotecan (Camptosar) (29 trials)
keyhole limpet hemocyanin (1 trial)
lenalidomide (revlimid) (13 trials)
lenvatinib (lenvima) (1 trial)
leuprolide (lupron) (3 trials)
levocetirizine (xyzal) (1 trial)
levoleucovorin (fusilev) (1 trial)
loratadine (claritin) (1 trial)
necitumumab (portrazza) (1 trial)
octreotide (sandostatin) (1 trial)
olaparib (lynparza) (3 trials)
ondansetron (zofran) (2 trials)
osimertinib (tagrisso) (2 trials)
palbociclib (ibrance) (5 trials)
panitumumab (vectibix) (3 trials)
panobinostat (farydak) (4 trials)
pembrolizumab (keytruda) (2 trials)
pemetrexed (alimta) (23 trials)
peripheral blood hematopoietic cell (1 trial)
polatuzumab vedotin (Polivy) (10 trials)
pomalidomide (pomalyst) (3 trials)
regorafenib (stivarga) (1 trial)
romidepsin (istodax) (1 trial)
rosuvastatin (crestor) (2 trials)
sargramostim (leukine) (5 trials)
sirolimus (rapamune) (5 trials)
sorafenib (nexavar) (3 trials)
tacrolimus (prograf) (2 trials)
talazoparib (talzenna) (3 trials)
temozolomide (temodar) (25 trials)
temsirolimus (torisel) (4 trials)
topotecan (hycamtin) (6 trials)
valaciclovir (Valtrex) (1 trial)
valproic acid (depakene) (1 trial)
vedolizumab (entyvio) (1 trial)
venlafaxine (effexor) (1 trial)
verteporfin (visudyne) (1 trial)
vinblastine (velban) (3 trials)
vinorelbine (navelbine) (10 trials)
vismodegib (erivedge) (28 trials)
Key: Genentech (94) Acquired (1)
budesonide (rhinocort) (1 trial)
celecoxib (celebrex) (1 trial)
daunorubicin (cerubidine) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
florbetapir (Amyvid) (1 trial)
human coagulation factor ix (Mononine) (1 trial)
interferon gamma-1b (actimmune) (1 trial)
itraconazole (sporanox) (5 trials)
ketoconazole (nizoral) (3 trials)
moxifloxacin (avelox) (1 trial)
omeprazole (prilosec) (1 trial)
posaconazole (noxafil) (1 trial)
Abdominal Abscess (Phase 2)
Abscess (Phase 2)
Acquired Immunodeficiency Syndrome (Phase 1)
Acute Lung Injury (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Clear Cell (Phase 2)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Adenoma, Islet Cell (Phase 3)
Adnexal Diseases (Phase 1)
Adrenocortical Carcinoma (Phase 2)
Aggression (Phase 1)
AIDS-Related Complex (Phase 1)
Airway Obstruction (Phase 2)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Alzheimer Disease (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Angioid Streaks (Phase 2)
Anorexia (Phase 2)
Anorexia Nervosa (Phase 2)
Anthracosis (Phase 2)
Antiphospholipid Syndrome (Phase 2)
Arthritis (Phase 4)
Arthritis, Juvenile (Phase 2)
Arthritis, Psoriatic (Phase 1)
Arthritis, Rheumatoid (Phase 4)
Ascites (Phase 2)
Asthma (Phase 4)
Astrocytoma (Phase 2)
Atherosclerosis (Phase 2)
Atrophy (Phase 2)
Autoimmune Diseases (Phase 2)
Bacteremia (Phase 1)
Basal Cell Nevus Syndrome (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Bone Diseases, Metabolic (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Brenner Tumor (Phase 2)
Bronchiolitis (Phase 1)
Bronchiolitis Obliterans (Phase 1)
Burkitt Lymphoma (Phase 1)
Carcinoid Tumor (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Endometrioid (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 2)
Carcinosarcoma (Phase 2)
Cardiovascular Diseases (Phase 2)
Cataract (Phase 1)
Central Serous Chorioretinopathy (Phase 1)
Cerebral Hemorrhage (Phase 3)
Cholangiocarcinoma (Phase 2)
Cholangitis (Phase 1)
Cholangitis, Sclerosing (Phase 1)
Chondrosarcoma (Phase 2)
Choroidal Neovascularization (Phase 4)
Choroiditis (Phase 2)
Churg-Strauss Syndrome (Phase 2)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 4)
Communicable Diseases (Phase 4)
Conjunctival Neoplasms (Phase 1)
Corneal Neovascularization (Phase 1)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Coronavirus Infections (Phase 2)
Crohn Disease (Phase 2)
Cystadenocarcinoma (Phase 2)
Cystadenocarcinoma, Serous (Phase 2)
Cystic Fibrosis (Phase 4)
Cytomegalovirus Infections (Phase 2)
Deafness (Phase 3)
Depression (Phase 1)
Dermatitis (Phase 4)
Dermatitis, Atopic (Phase 4)
Dermatomyositis (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 1)
Diabetic Foot (Phase 2)
Diabetic Nephropathies (Phase 2)
Diabetic Retinopathy (Phase 3)
Diarrhea (Phase 2)
Digestive System Diseases (Phase 1)
Digestive System Neoplasms (Phase 1)
Disease (Phase 2)
Disease Progression (Phase 2)
Dissociative Disorders (Phase 3)
Dry Eye Syndromes (Phase 2)
Dwarfism (Phase 3)
Dwarfism, Pituitary (Phase 4)
Eczema (Phase 2)
Edema (Phase 4)
Embolism (Phase 4)
Encephalitis (Phase 2)
Endocrine Gland Neoplasms (Phase 2)
Endocrine System Diseases (Phase 4)
Endometrial Neoplasms (Phase 2)
Eosinophilic Esophagitis (Phase 1)
Epistaxis (Phase 1)
Erdheim-Chester Disease (Phase 2)
Erythema (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophagitis (Phase 1)
Eye Diseases (Phase 1)
Failure to Thrive (Phase 4)
Fallopian Tube Neoplasms (Phase 2)
Fatigue (Phase 2)
Fatty Liver (Phase 2)
Feeding and Eating Disorders (Phase 2)
Fibrosis (Phase 4)
Food Hypersensitivity (Phase 3)
Foot Ulcer (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Diseases (Phase 1)
Gastrointestinal Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 2)
Geographic Atrophy (Phase 2)
Giant Cell Arteritis (Phase 2)
Glaucoma (Phase 3)
Glaucoma, Neovascular (Phase 2)
Glaucoma, Open-Angle (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Glomerulonephritis (Phase 2)
Glomerulonephritis, IGA (Phase 4)
Glomerulonephritis, Membranous (Phase 3)
Glomerulosclerosis, Focal Segmental (Phase 2)
Gonadal Dysgenesis (Phase 4)
Graft vs Host Disease (Phase 2)
Granulomatosis with Polyangiitis (Phase 4)
Hashimoto Disease (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hearing Loss (Phase 3)
Hearing Loss, Sensorineural (Phase 3)
Heart Diseases (Phase 2)
Hemangioblastoma (Phase 1)
Hemangiosarcoma (Phase 2)
Hemophilia A (Phase 4)
Hemorrhage (Phase 3)
Hepatic Insufficiency (Phase 1)
Hepatitis (Phase 1)
Hepatitis C (Phase 1)
Hepatitis C, Chronic (Phase 1)
Hermanski-Pudlak Syndrome (Phase 2)
Hidradenitis (Phase 1)
Hidradenitis Suppurativa (Phase 1)
Histiocytic Disorders, Malignant (Phase 2)
Histiocytic Sarcoma (Phase 2)
Histiocytoma (Phase 2)
Histiocytoma, Benign Fibrous (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 2)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
Histiocytosis, Sinus (Phase 2)
Histoplasmosis (Phase 2)
HIV Infections (Phase 3)
Hodgkin Disease (Phase 2)
Hypersensitivity (Phase 4)
Hypertension (Phase 2)
Hypertension, Renal (Phase 2)
Hypogonadism (Phase 4)
Hypopituitarism (Phase 4)
Idiopathic Pulmonary Fibrosis (Phase 3)
Infarction (Phase 4)
Infections (Phase 4)
Inflammation (Phase 2)
Inflammatory Breast Neoplasms (Phase 2)
Influenza, Human (Phase 2)
Insulin Resistance (Phase 1)
Intraocular Lymphoma (Phase 1)
Ischemia (Phase 1)
Keratoconjunctivitis Sicca (Phase 2)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Neoplasms (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 3)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Liposarcoma (Phase 2)
Liposarcoma, Myxoid (Phase 2)
Liver Cirrhosis (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Liver Diseases (Phase 1)
Liver Failure (Phase 1)
Liver Neoplasms (Phase 2)
Lung Diseases (Phase 4)
Lung Diseases, Interstitial (Phase 3)
Lung Diseases, Obstructive (Phase 2)
Lung Injury (Phase 2)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 3)
Lymphedema (Phase 1)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoproliferative Disorders (Phase 2)
Macular Degeneration (Phase 4)
Macular Edema (Phase 4)
Malignant Carcinoid Syndrome (Phase 3)
Malnutrition (Phase 1)
Medulloblastoma (Phase 2)
Melanoma (Phase 3)
Meningeal Carcinomatosis (Phase 2)
Meningeal Neoplasms (Phase 2)
Meningioma (Phase 2)
Meningitis (Phase 2)
Menopause, Premature (Phase 4)
Mental Disorders (Phase 2)
Mesothelioma (Phase 2)
Microscopic Polyangiitis (Phase 4)
Mixed Tumor, Mullerian (Phase 2)
Motor Neuron Disease (Phase 2)
Multiple Chronic Conditions (Phase 3)
Multiple Endocrine Neoplasia (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Muscle Weakness (Phase 2)
Myasthenia Gravis (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 2)
Myoclonus (Phase 2)
Myopia, Degenerative (Phase 2)
Myositis (Phase 2)
Nasal Polyps (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasm Recurrence, Local (Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms by Histologic Type (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Glandular and Epithelial (Phase 1)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Squamous Cell (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Neovascularization, Pathologic (Phase 4)
Nephritis (Phase 3)
Nephritis, Interstitial (Phase 2)
Nephrosis (Phase 3)
Nephrotic Syndrome (Phase 3)
Nerve Sheath Neoplasms (Phase 2)
Neurilemmoma (Phase 2)
Neuroblastoma (Phase 2)
Neurodegenerative Diseases (Phase 2)
Neuroendocrine Tumors (Phase 3)
Neurofibroma (Phase 2)
Neurofibromatoses (Phase 2)
Neurofibromatosis 1 (Phase 2)
Neurofibromatosis 2 (Phase 2)
Neurofibrosarcoma (Phase 2)
Neuroma, Acoustic (Phase 2)
Neuromyelitis Optica (Phase 1)
Nevus (Phase 2)
Nevus, Pigmented (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity (Phase 2)
Ocular Motility Disorders (Phase 2)
Odontogenic Tumors (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Optic Nerve Diseases (Phase 1)
Optic Neuropathy, Ischemic (Phase 1)
Orbital Diseases (Phase 2)
Osteoporosis (Phase 2)
Osteosarcoma (Phase 2)
Otitis Media (Phase 4)
Ovarian Diseases (Phase 1)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 1)
Pancreatic Diseases (Phase 1)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 2)
Papilledema (Phase 2)
Paraproteinemias (Phase 2)
Pathologic Processes (Phase 1)
Peanut Hypersensitivity (Phase 3)
Pelvic Neoplasms (Phase 2)
Pemphigoid, Benign Mucous Membrane (Phase 2)
Pemphigoid, Bullous (Phase 4)
Pemphigus (Phase 3)
Peripheral Nervous System Diseases (Phase 2)
Peritoneal Neoplasms (Phase 2)
Pharyngeal Neoplasms (Phase 1)
Pleural Effusion (Phase 3)
Pneumoconiosis (Phase 2)
Pneumonia (Phase 3)
Polymyalgia Rheumatica (Phase 2)
Polymyositis (Phase 2)
Polyps (Phase 1)
Postphlebitic Syndrome (Phase 3)
Postthrombotic Syndrome (Phase 3)
Precancerous Conditions (Phase 2)
Preleukemia (Phase 2)
Primary Ovarian Insufficiency (Phase 4)
Prostatic Neoplasms (Phase 2)
Proteinuria (Phase 3)
Pseudoxanthoma Elasticum (Phase 2)
Psoriasis (Phase 4)
Psychotic Disorders (Phase 2)
Pterygium (Phase 1)
Pulmonary Alveolar Proteinosis (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Pulmonary Embolism (Phase 4)
Pulmonary Fibrosis (Phase 3)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 3)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Respiratory Hypersensitivity (Phase 4)
Respiratory Insufficiency (Phase 2)
Retinal Degeneration (Phase 2)
Retinal Detachment (Phase 3)
Retinal Diseases (Phase 3)
Retinal Telangiectasis (Phase 2)
Retinal Vasculitis (Phase 3)
Retinal Vein Occlusion (Phase 4)
Retroperitoneal Fibrosis (Phase 2)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Sarcoma, Synovial (Phase 2)
Schizophrenia (Phase 2)
Scleritis (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Localized (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 4)
Scotoma (Phase 3)
Septo-Optic Dysplasia (Phase 4)
Severe Acute Respiratory Syndrome (Phase 2)
Sialadenitis (Phase 2)
Sinusitis (Phase 4)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Splenomegaly (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
ST Elevation Myocardial Infarction (Phase 2)
Stomach Neoplasms (Phase 3)
Stroke (Phase 3)
Syndrome (Phase 4)
Systemic Vasculitis (Phase 4)
Telangiectasia, Hereditary Hemorrhagic (Phase 1)
Telangiectasis (Phase 2)
Thromboembolism (Phase 3)
Thrombosis (Phase 3)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Trisomy (Phase 1)
Turner Syndrome (Phase 4)
Ulcer (Phase 2)
Ureteral Neoplasms (Phase 2)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 2)
Urologic Diseases (Phase 2)
Urologic Neoplasms (Phase 2)
Urticaria (Phase 4)
Uterine Cervical Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)
Uveal Neoplasms (Phase 2)
Uveitis (Phase 2)
Vaginal Neoplasms (Phase 2)
Vascular Diseases (Phase 2)
Vasculitis (Phase 4)
Venous Thromboembolism (Phase 3)
Venous Thrombosis (Phase 3)
Vitelliform Macular Dystrophy (Phase 2)
Vitreous Detachment (Phase 2)
von Hippel-Lindau Disease (Phase 2)
Vulvar Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Weight Loss (Phase 2)
Wet Macular Degeneration (Phase 4)
Wounds and Injuries (Phase 2)
Xanthogranuloma, Juvenile (Phase 2)